Biocon Limited

NSEI:BIOCON Voorraadrapport

Marktkapitalisatie: ₹396.7b

Biocon Beheer

Beheer criteriumcontroles 4/4

De CEO Biocon is Siddharth Mittal, benoemd in Dec2019, heeft een ambtstermijn van 4.92 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 57.31M, bestaande uit 100% salaris en 0% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.069% van de aandelen van het bedrijf, ter waarde ₹ 275.38M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 3 jaar.

Belangrijke informatie

Siddharth Mittal

Algemeen directeur

₹57.3m

Totale compensatie

Percentage CEO-salaris100.0%
Dienstverband CEO4.9yrs
Eigendom CEO0.07%
Management gemiddelde ambtstermijn2.3yrs
Gemiddelde ambtstermijn bestuur3yrs

Recente managementupdates

Recent updates

Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Nov 01
Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

Oct 14
Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Sep 20
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Jun 29
Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Is Biocon (NSE:BIOCON) A Risky Investment?

Jun 11
Is Biocon (NSE:BIOCON) A Risky Investment?

Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Jun 11
Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

May 24
Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

May 23
Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Mar 20
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Feb 12
Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Jan 23
Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

Jan 03
Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Nov 13
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Aug 03
Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Jul 03
Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 02
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

May 26
Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Mar 28
Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Feb 26
Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Dec 17
Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Sep 05
Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 13
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

May 26
Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

Analyse CEO-vergoeding

Hoe is Siddharth Mittal's beloning veranderd ten opzichte van Biocon's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

₹14b

Jun 30 2024n/an/a

₹16b

Mar 31 2024₹57m₹57m

₹10b

Dec 31 2023n/an/a

₹12b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹48m₹48m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹6b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹42m₹42m

₹6b

Dec 31 2021n/an/a

₹7b

Sep 30 2021n/an/a

₹7b

Jun 30 2021n/an/a

₹7b

Mar 31 2021₹43m₹43m

₹7b

Dec 31 2020n/an/a

₹6b

Sep 30 2020n/an/a

₹6b

Jun 30 2020n/an/a

₹7b

Mar 31 2020₹49m₹31m

₹8b

Compensatie versus markt: De totale vergoeding ($USD 678.72K ) Siddharth } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 589.97K ).

Compensatie versus inkomsten: De vergoeding van Siddharth is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Siddharth Mittal (46 yo)

4.9yrs

Tenure

₹57,310,000

Compensatie

Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46yrs₹38.43m40.49%
₹ 160.6b
Siddharth Mittal
MD, CEO & Director4.9yrs₹57.31m0.069%
₹ 275.4m
Peter James Bains
Group Chief Executive Officer1.2yrs₹1.91mgeen gegevens
Mukesh Kamath
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Arun Gupta
Head of Operations1.6yrsgeen gegevensgeen gegevens
Atanu Roy
Group Chief Information Officer4.2yrsgeen gegevensgeen gegevens
Saurabh Paliwal
Head of Investor Relations2.3yrsgeen gegevensgeen gegevens
Mayank Verma
Company Secretary & Compliance Officer5.3yrs₹5.75mgeen gegevens
Seema Ahuja
Global Head of Communications & Corporate Brandno datageen gegevensgeen gegevens
Maninder Puri
Head of Human Resourcesno datageen gegevensgeen gegevens
Paul Thomas
Chief Commercial Officerno datageen gegevensgeen gegevens
Abhijit Zutshi
Commercial Head of Biocon Global Genericsno datageen gegevens0.019%
₹ 73.6m

2.3yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BIOCON wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46yrs₹38.43m40.49%
₹ 160.6b
Siddharth Mittal
MD, CEO & Director4.9yrs₹57.31m0.069%
₹ 275.4m
Ravi Mazumdar
Non-Executive Non-Independent Director24.3yrs₹6.23m0.44%
₹ 1.8b
Bobby Parikh
Independent Non-Executive Director6.3yrs₹7.81mgeen gegevens
Naina Lal Kidwai
Additional Non-Executive Independent Director2.6yrs₹6.24mgeen gegevens
Satish Garg
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Nicholas Haggar
Independent Directorless than a year₹5.20mgeen gegevens
Shashank Joshi
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Rekha Menon
Independent Director1.3yrs₹5.70mgeen gegevens
Eric Mazumdar
Non-Executive Director3yrs₹5.57m0.27%
₹ 1.1b
John Petrie
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Atul Dhawan
Non-Executive and Independent Directorless than a yeargeen gegevensgeen gegevens

3.0yrs

Gemiddelde duur

62.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BIOCON wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).